甲状旁腺激素相关蛋白(PTHrP)重组蛋白

Recombinant Parathyroid Hormone Related Protein (PTHrP)

PTHLH; HHM; PTHR; PLP; Osteostatin; Parathyroid Hormone Like Hormone

  • 甲状旁腺激素相关蛋白(PTHrP)重组蛋白 产品包装(模拟)
  • 甲状旁腺激素相关蛋白(PTHrP)重组蛋白 产品包装(模拟)
  • 甲状旁腺激素相关蛋白(PTHrP)重组蛋白 Figure . Gene Sequencing (extract)
  • RPA819Hu01.jpg Figure. SDS-PAGE
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPA819Hu01 甲状旁腺激素相关蛋白(PTHrP)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
CPA819Hu21 甲状旁腺激素相关蛋白(PTHrP)卵白蛋白偶联物 Immunogen; SDS-PAGE; WB.
CPA819Hu22 甲状旁腺激素相关蛋白(PTHrP)卵白蛋白偶联物 Immunogen; SDS-PAGE; WB.
CPA819Hu32 甲状旁腺激素相关蛋白(PTHrP)钥孔血蓝蛋白偶联物 Immunogen; SDS-PAGE; WB.
CPA819Hu31 甲状旁腺激素相关蛋白(PTHrP)钥孔血蓝蛋白偶联物 Immunogen; SDS-PAGE; WB.
PAA819Hu01 甲状旁腺激素相关蛋白(PTHrP)多克隆抗体 WB; IHC; ICC; IP.
PAA819Hu08 甲状旁腺激素相关蛋白(PTHrP)多克隆抗体 WB; IHC; ICC; IP.
LAA819Hu81 甲状旁腺激素相关蛋白(PTHrP)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
LAA819Hu71 甲状旁腺激素相关蛋白(PTHrP)多克隆抗体(生物素标记) WB; IHC; ICC.
MAA819Hu22 甲状旁腺激素相关蛋白(PTHrP)单克隆抗体 WB; IHC; ICC; IP.
SEA819Hu 甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
CEA819Hu 甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA819Hu 甲状旁腺激素相关蛋白(PTHrP)检测试剂盒(化学发光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.
KSA819Hu11 甲状旁腺激素相关蛋白(PTHrP)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
Clinical and Experimental Metastasis Characterization of a new renal cell carcinoma bone metastasis mouse model [PubMed: 20443133]
Stem Cells and Development Temporal activation of β-catenin signaling in the chondrogenic process of mesenchymal stem cells affects the phenotype of the cartilage generated. [PubMed: 22133004]
International journal of biological sciences PTHrP Expression in Human MDA-MB-231 Breast Cancer Cells Is Critical for Tumor Growth and Survival and Osteoblast Inhibition [PubMed: PMC3753447]
Investigational New Drugs Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts [Pubmed: 23673814]
Toxicology and Applied Pharmacology Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment [Pubmed:24463094]
Arch Gynecol Obstet. Calcitonin gene-and parathyroid hormone-related peptides in normotensive and preeclamptic pregnancies: a nested case–control study [Pubmed:24943060]
PLoS One 15-Deoxy-Δ12, 14-Prostaglandin J2 Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss [PubMed: 25859665]
Endocrinology A role for the calcitonin receptor to limit bone loss during lactation in female mice by inhibiting osteocytic osteolysis [PubMed: 26135836]
Tumour Biol Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation. [Pubmed:27312487]
35 Hedgehog signaling in bone regulates whole-body energy metabolism through a bone–adipose endocrine relay mediated by PTHrP and adiponectin [pubmed:27740628]
Bone Lactation induces increases in the RANK/RANKL/OPG system in maxillary bone [Pubmed:29382610]
留言咨询